Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
Nature Reviews Nephrology 13, 429 (2017).
doi:10.1038/nrneph.2017.60
Authors: Mathias Haarhaus, Vincent Brandenburg, Kamyar Kalantar-Zadeh, Peter Stenvinkel & Per Magnusson
Cardiovascular disease is the main cause of early death in the settings of chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), and ageing. Cardiovascular events can be caused by an imbalance between promoters and inhibitors of mineralization, which leads to vascular calcification. This process
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Mathias Haarhaus Vincent Brandenburg Kamyar Kalantar-Zadeh Peter Stenvinkel Per Magnusson Tags: Review Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Urology & Nephrology